- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04795778
The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients
The Validity and Reliability of FIT-HaNSA (Functional Impairment Test-Hand and Neck/Shoulder/Arm) in Breast Cancer Patients
Breast cancer is the most common type of cancer among women and covers 25% of all cancers. After mastectomy and reconstruction, many patients develop various upper extremity complications such as joint movement limitation, pain, lymphedema, and axillary cord. Because of such upper extremity problems, evaluation and treatment of upper extremity functions are important. Upper extremity functions are generally evaluated with questionnaires filled out by the patients themselves and which reflect their own perspectives subjectively. However, these questionnaires cannot reflect the observations and evaluations of the clinicians. Performance tests are important for clinicians to make decisions.
With this study, we want to examine the usability of the FIT-HaNSA test in the evaluation of upper extremity functions in patients with breast cancer. Our hypothesis; The FıtHaNSA test is successful in evaluating the upper extremity function in patients with breast cancer.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
-
Ankara, Turquie, 06560
- Recrutement
- Inci Ayas
-
Contact:
- inci ayas
- Numéro de téléphone: 0 312 216 26 21
- E-mail: inciayass@gmail.com
-
Contact:
- ilke keser
- Numéro de téléphone: 0 312 216 26 21
- E-mail: ilkekeser@yahoo.com
-
Sous-enquêteur:
- elif sakizli erdal
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Those whose treatments for breast cancer have been completed 18 years and over
Exclusion Criteria:
- Have a history of upper extremity surgery, excluding breast cancer surgery Have a history of upper extremity trauma Those who have orthopedic, neurological, rheumatological or cognitive impairments that may interfere with the application of the test.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
Patients with breast cancer
Breast cancer patients with or without breast cancer surgery, with or without mastectomy, with or without lymphedema
|
Control group
Healty individuals with no disease
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
FIT-HaNSA test for upper extremity performance
Délai: For the patient group; at least 3 months after all treatments have been completed
|
FIT-HaNSA protocol includes 3 steps.In the first step of the test 3 weights of 1kg are placed on the shelf at the waist level of the individual at 10 cm intervals.The person moves these weights in rows to the 25 cm upper rack and then place them back on the lower rack.The person is asked to continue this process for 5 minutes.In the second step of the test, the first shelf is placed at eye level, the second shelf is placed 25 cm below it and the procedures in the first step are repeated.In the 3rd step, a wooden plate with 3 holes is placed perpendicular to the shelf at eye level of the individual.The hole in the middle is left empty by placing nuts and bolts in the first and third holes before.
The individual must return to the starting point in order by attaching the bolt in the first hole to the second hole, the bolt in the third hole to the first hole and finally the bolt in the second hole to the third hole and this process is 5 minutes.
|
For the patient group; at least 3 months after all treatments have been completed
|
Upper extremity disability
Délai: For the patient group; at least 3 months after all treatments have been completed
|
Upper extremity disability will be evaluated with DASH questionnaire (Disabilities of the Arm, Shoulder and Hand).
It is a questionnaire consisting of 30 questions that evaluates the dysfunctions of the entire upper extremity.
It consists of questions evaluating the degree of difficulty in performing different activities using the upper extremity in daily life (21 questions), pain, numbness, joint stiffness and weakness symptoms (5 questions), social life, sleep, work and psychological status (4 questions) in the last week.
|
For the patient group; at least 3 months after all treatments have been completed
|
Upper extremity functionality
Délai: For the patient group; at least 3 months after all treatments have been completed
|
Upper extremity functionality will be evaluated with Upper Extremity Functional Index (UEFI).
It is a questionnaire consisting of 20 questions that questions the functional difficulty of the upper extremity in daily life activities.
Each question is scored between 0 and 4 (0: extremely difficult, 4: no difficulty).
|
For the patient group; at least 3 months after all treatments have been completed
|
Shoulder disability
Délai: For the patient group; at least 3 months after all treatments have been completed
|
Shoulder disability will be evaluated with Shoulder Pain and Disabilty Index (SPADI).
The scale, which consists of 13 questions in total, has two subsections as pain and disability.
The pain section consists of 5 questions describing the pain of the patient, and the disability section consists of 8 questions that indicate the degree of difficulty experienced when using the upper extremity.
Each question is scored from 0 to 10 (0 is no difficulty, 10 is very difficult).
|
For the patient group; at least 3 months after all treatments have been completed
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: inci ayas, Gazi University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IAyas2
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer du sein
-
AstraZenecaRecrutementAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerEspagne, États-Unis, Belgique, Royaume-Uni, France, Hongrie, Canada, Corée, République de, Australie